Utah Retirement Systems’s Juno Therapeutics, Inc. JUNO Stock Holding History

Utah Retirement Systems’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,700	Closed	-$581K	–	989
2017 Q4	$581K	Buy	12,700 +1,100	+9%	+$54.9K	0.01%	872
2017 Q3	$520K	Hold	11,600	–	–	0.01%	894
2017 Q2	$347K	Buy	11,600 +200	+2%	+$4.93K	0.01%	955
2017 Q1	$252K	Hold	11,400	–	–	0.01%	958
2016 Q4	$215K	Hold	11,400	–	–	0.01%	969
2016 Q3	$342K	Hold	11,400	–	–	0.01%	938
2016 Q2	$438K	Buy	+11,400	New	+$473K	0.01%	906

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Utah Retirement Systems's JUNO Position: Q1 2018 in Review

Utah Retirement Systems sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 12,700 shares — an estimated $581K sold.

Utah Retirement Systems first reported a position in JUNO in Q2 2016 and held it in 7 quarters. The position peaked at $581K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Utah Retirement Systems reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Utah Retirement Systems sold 12,700 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $581K.
Utah Retirement Systems first reported a position in Juno Therapeutics, Inc. in Q2 2016 and held it in 7 quarters.
Utah Retirement Systems's Juno Therapeutics, Inc. position peaked at $581K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Utah Retirement Systems's 13F filing for Q1 2018, filed 15 May 2018.